Myeloid neoplasms arising after methotrexate therapy for autoimmune rheumatological diseases do not exhibit poor-risk molecular features
Files
(Published version)
Date
2024
Authors
Wechalekar, M.D.
Zhao, L.-P.
Kutyna, M.M.
Hong, L.E.
Li, J.
Hung, K.
Scott, H.S.
Brown, A.
Hahn, C.C.
Kassahn, K.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Blood Cancer Journal, 2024; 14(1):116-1-116-5
Statement of Responsibility
Mihir D. Wechalekar, Lin-Pierre Zhao, Monika M. Kutyna, Lih En Hong, Joule Li, Kevin Hung, Hamish S. Scott, Anna Brown, Christopher C. Hahn, Karin Kassahn, Dariusz Ladon, David T. Yeung, Daniel Thomas, Mrinal Patnaik, Susanna Proudman, Lionel Ades, Mithun V. Shah, Chung H. Kok, and Devendra K. Hiwase
Conference Name
Abstract
School/Discipline
Dissertation Note
Provenance
Description
Correspondence
Data source: Supplementary materials, https://doi.org/10.1038/s41408-024-01093-9
Access Status
Rights
© Crown 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http:// creativecommons.org/licenses/by/4.0/.